MicroVision Narrows Losses, Boosts Liquidity Amid Revenue Dip

TL;DR

**MicroVision is burning cash but has shored up its balance sheet with new capital, giving it runway to execute on its lidar tech.**

AI Summary

MicroVision, Inc. reported a net loss of $14.2 million for the three months ended September 30, 2025, a slight improvement from the $15.5 million net loss in the same period of 2024. For the nine months ended September 30, 2025, the net loss was $57.2 million, an improvement from $65.8 million in 2024. Revenue for the three months ended September 30, 2025, increased to $241 thousand from $190 thousand in 2024, but for the nine months, revenue significantly decreased to $985 thousand from $3.0 million in 2024. The company's total assets grew to $150.8 million as of September 30, 2025, from $121.2 million at December 31, 2024, primarily driven by an increase in cash and cash equivalents to $72.8 million from $54.5 million. Shareholder equity also saw a substantial increase to $90.7 million from $48.8 million, largely due to net proceeds from the issuance of common stock and warrants totaling $73.3 million and conversions of notes payable amounting to $22.0 million. The company maintains $99.5 million in total liquidity and anticipates sufficient cash to fund operations for at least the next 12 months.

Why It Matters

MicroVision's ability to reduce its net loss while significantly increasing its cash reserves and shareholder equity is a critical signal for investors, demonstrating improved financial stability despite a notable drop in nine-month revenue. The company's focus on 'deterministic AI at the edge' for ADAS and autonomy positions it in a highly competitive and rapidly evolving market, where sustained R&D investment is crucial. For employees, this financial stability could mean continued investment in innovation and job security. Customers in the automotive, robotics, and industrial sectors will be watching for the successful commercialization of their lidar and software solutions, especially given the concentration of revenue from a few key clients. The broader market will observe if MicroVision can translate its technological advancements and increased liquidity into sustainable revenue growth and market share against larger competitors.

Risk Assessment

Risk Level: medium — The company continues to incur significant net losses, with a $57.2 million net loss for the nine months ended September 30, 2025. Revenue for the nine months decreased substantially from $3.0 million in 2024 to $985 thousand in 2025, indicating challenges in commercialization. While liquidity has improved to $99.5 million, the company's reliance on a few key customers (e.g., 51% of 9-month revenue from one agricultural equipment manufacturer) and single-source suppliers presents concentration risks.

Analyst Insight

Investors should monitor MicroVision's progress in converting its R&D investments and increased liquidity into tangible revenue growth and reduced operating losses. Pay close attention to future announcements regarding customer contracts and product commercialization, as the current revenue figures do not yet justify the increased capital. Consider this a speculative long-term play on lidar technology, but be aware of the high execution risk.

Financial Highlights

debt To Equity

0.0

revenue

$985K

operating Margin

N/A

total Assets

$150.8M

total Debt

$0.0

net Income

-$57.2M

eps

N/A

gross Margin

N/A

cash Position

$72.8M

revenue Growth

-67.2%

Revenue Breakdown

Key Numbers

• $57.2M — Net Loss (9 months ended Sep 30, 2025) (Improved from $65.8M in 2024)
• $985K — Revenue (9 months ended Sep 30, 2025) (Decreased significantly from $3.0M in 2024)
• $72.8M — Cash and Cash Equivalents (Sep 30, 2025) (Increased from $54.5M at Dec 31, 2024)
• $99.5M — Total Liquidity (Sep 30, 2025) (Includes cash and short-term investments)
• $90.7M — Total Shareholders' Equity (Sep 30, 2025) (Increased from $48.8M at Dec 31, 2024)
• $73.3M — Net proceeds from issuance of common stock and warrants (Contributed to increased liquidity and equity)
• $22.0M — Common stock issued in conversions of notes payable (Contributed to increased equity)
• 51% — Revenue concentration (9 months ended Sep 30, 2025) (From a leading manufacturer of agricultural equipment)
• $43.3M — Net cash used in operating activities (9 months ended Sep 30, 2025) (Improved from $53.5M in 2024)
• $67.8M — Net cash provided by financing activities (9 months ended Sep 30, 2025) (Significantly increased from $26.2M in 2024)

Key Players & Entities

• MICROVISION, INC. (company) — Registrant
• Nasdaq Stock Market LLC (regulator) — Exchange where common stock is registered
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for financial statements
• FASB (regulator) — Financial Accounting Standards Board
• Executive Management team (person) — Chief Operating Decision Maker (CODM)
• Redmond, Washington (location) — Company engineering team location
• Hamburg, Germany (location) — Company engineering team location
• Ibeo (company) — Acquired business

FAQ

Risk Factors

• Sustained Operating Losses and Need for Future Financing [high — financial]: The company has a history of net losses and negative cash flows from operations. For the nine months ended September 30, 2025, the net loss was $57.2 million. While the company believes it has sufficient cash to fund operations for at least the next 12 months, future financing may be required to support ongoing operations and strategic initiatives.
• Dependence on Key Customers and Market Adoption [medium — market]: Revenue concentration exists, with 51% of revenue for the nine months ended September 30, 2025, coming from a leading manufacturer of agricultural equipment. The company's success is dependent on the adoption of its technology by customers and the ability to secure new customers and markets.
• Product Development and Commercialization Challenges [medium — operational]: MicroVision is developing advanced technologies, including lidar and augmented reality. The successful commercialization of these products involves significant research and development, manufacturing scale-up, and market acceptance, all of which carry inherent risks.
• Intellectual Property and Competition [medium — regulatory]: The company operates in a competitive landscape with other players in the lidar and augmented reality markets. Protecting its intellectual property and navigating potential patent disputes is crucial for its long-term success.

Industry Context

MicroVision operates in the advanced sensing and photonics technology sector, focusing on lidar and augmented reality solutions. This industry is characterized by rapid technological advancements, significant R&D investment, and a competitive landscape with both established players and emerging startups. Market adoption is driven by applications in automotive, industrial, and consumer electronics sectors.

Regulatory Implications

The company must comply with various regulations related to product safety, data privacy, and intellectual property. Potential changes in trade policies or international regulations could impact its supply chain and market access. Compliance with SEC reporting requirements is also a continuous obligation.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-09-30: Quarterly Financial Report (10-Q) — Provides updated financial performance, balance sheet, and cash flow information for the nine months ended September 30, 2025.
• 2024-12-31: Previous Fiscal Year End — Establishes the baseline for comparison of assets and equity as of the end of the prior fiscal year.

Glossary

Net Loss

The total expenses incurred by a company exceed the total revenues earned over a specific period. (Indicates the company's profitability, with a net loss of $57.2 million for the nine months ended September 30, 2025.)

Cash and Cash Equivalents

Highly liquid investments with maturities of three months or less from the date of purchase. (Represents the company's readily available funds, which increased to $72.8 million as of September 30, 2025.)

Shareholder Equity

The residual interest in the assets of an entity after deducting all its liabilities. (Shows the net worth of the company attributable to its shareholders, which significantly increased to $90.7 million.)

Net Proceeds

The amount of money received from an issuance of securities after deducting any underwriting discounts and commissions. (Highlights the capital raised through stock and warrant issuance, totaling $73.3 million, which bolstered equity and liquidity.)

Notes Payable

Written promises to pay a specific amount of money on demand or at a specified future date. (Indicates debt obligations that were converted into equity, contributing $22.0 million to shareholder equity.)

Total Liquidity

The total amount of readily available funds, including cash, cash equivalents, and short-term investments. (Measures the company's ability to meet its short-term obligations, reported at $99.5 million.)

Year-Over-Year Comparison

Compared to the prior year, MicroVision has shown an improvement in its net loss for both the three-month and nine-month periods ended September 30, 2025. However, revenue for the nine-month period has significantly declined. The company's balance sheet has strengthened considerably, with substantial increases in cash and shareholder equity, largely due to capital raised from stock and warrant issuances. Operating cash flow usage has decreased, while financing cash inflows have dramatically increased, reflecting the company's reliance on external funding.

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value per share MVIS The Nasdaq

Filing Documents

• form10-q.htm (10-Q) — 1268KB
• ex10-1.htm (EX-10.1) — 32KB
• ex31-1.htm (EX-31.1) — 12KB
• ex31-2.htm (EX-31.2) — 11KB
• ex32-1.htm (EX-32.1) — 6KB
• ex32-2.htm (EX-32.2) — 6KB
• form10-q_001.jpg (GRAPHIC) — 4KB
• 0001493152-25-021931.txt ( ) — 7624KB
• mvis-20250930.xsd (EX-101.SCH) — 54KB
• mvis-20250930_cal.xml (EX-101.CAL) — 85KB
• mvis-20250930_def.xml (EX-101.DEF) — 202KB
• mvis-20250930_lab.xml (EX-101.LAB) — 481KB
• mvis-20250930_pre.xml (EX-101.PRE) — 393KB
• form10-q_htm.xml (XML) — 1271KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) 3 Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 3 Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024 4 Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2025 and 2024 5 Condensed Consolidated Statements of Shareholders' Equity for the three and nine months ended September 30, 2025 and 2024 6 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 7 Notes to Condensed Consolidated Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 23

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 28

Controls and Procedures

Item 4. Controls and Procedures 28

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 29

Risk Factors

Item 1A. Risk Factors 29

Other Information

Item 5. Other Information 39

Exhibits

Item 6. Exhibits 40

Signatures

Signatures 41 2 PART I. ITEM 1. FINANCIAL STATEMENTS MicroVision, Inc. Condensed Consolidated Balance Sheets (In thousands, except per share data) (Unaudited) September 30, December 31, 2025 2024 Assets Current assets Cash and cash equivalents $ 72,832 $ 54,486 Investment securities, available-for-sale 26,676 20,216 Restricted cash, current 328 261 Accounts receivable, net of allowances 40 926 Inventory 8,131 2,294 Other current assets 6,969 4,287 Total current assets 114,976 82,470 Property and equipment, net 6,574 7,061 Operating lease right-of-use assets 15,365 16,746 Restricted cash, net of current portion 1,374 1,500 Intangible assets, net 10,281 10,972 Other assets 2,252 2,412 Total assets $ 150,822 $ 121,161 Liabilities and shareholders' equity Current liabilities Accounts payable $ 1,339 $ 1,132 Accrued liabilities 3,754 2,542 Contract liabilities 147 308 Derivative liability 1,856 14,581 Notes payable, current 28,963 24,248 Operating lease liabilities, current 3,154 2,682 Finance lease liabilities, current 14 - Other current liabilities 672 458 Total current liabilities 39,899 45,951 Notes payable, net of current portion - 8,754 Warrant liability 4,059 - Operating lease liabilities, net of current portion 14,434 15,954 Finance lease liabilities, net of current portion 31 - Other long-term liabilities 1,680 1,733 Total liabilities 60,103 72,392 Commitments and contingencies (Note 11) - - Shareholders' equity Preferred stock, par value $ 0.001 ; 25,000 shares authorized; zero and zero shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively - - Common stock, par value $ 0.001 ; 510,000 shares authorized; 302,358 and 224,993 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 302 225 Additional paid-in capital 1,009,272 910,825